Dysregulated CREB3 cleavage at the nuclear membrane induces karyoptosis-mediated cell death.


Journal

Experimental & molecular medicine
ISSN: 2092-6413
Titre abrégé: Exp Mol Med
Pays: United States
ID NLM: 9607880

Informations de publication

Date de publication:
13 Mar 2024
Historique:
received: 01 09 2023
accepted: 02 01 2024
revised: 17 12 2023
medline: 14 3 2024
pubmed: 14 3 2024
entrez: 14 3 2024
Statut: aheadofprint

Résumé

Cancer cells often exhibit resistance to apoptotic cell death, but they may be vulnerable to other types of cell death. Elucidating additional mechanisms that govern cancer cell death is crucial for developing new therapies. Our research identified cyclic AMP-responsive element-binding protein 3 (CREB3) as a crucial regulator and initiator of a unique cell death mechanism known as karyoptosis. This process is characterized by nuclear shrinkage, deformation, and the loss of nuclear components following nuclear membrane rupture. We found that the N-terminal domain (aa 1-230) of full-length CREB3 (CREB3-FL), which is anchored to the nuclear inner membrane (INM), interacts with lamins and chromatin DNA. This interaction maintains a balance between the outward force exerted by tightly packed DNA and the inward constraining force, thereby preserving INM integrity. Under endoplasmic reticulum (ER) stress, aberrant cleavage of CREB3-FL at the INM leads to abnormal accumulation of the cleaved form of CREB3 (CREB3-CF). This accumulation disrupts the attachment of CREB3-FL to the INM, resulting in sudden rupture of the nuclear membrane and the onset of karyoptosis. Proteomic studies revealed that CREB3-CF overexpression induces a DNA damage response akin to that caused by UVB irradiation, which is associated with cellular senescence in cancer cells. These findings demonstrated that the dysregulation of CREB3-FL cleavage is a key factor in karyoptotic cell death. Consequently, these findings suggest new therapeutic strategies in cancer treatment that exploit the process of karyoptosis.

Identifiants

pubmed: 38480902
doi: 10.1038/s12276-024-01195-1
pii: 10.1038/s12276-024-01195-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Catholic University of Korea (The Catholic University of Korea)
ID : M-2023-B0002-00003
Organisme : Ministry of Science, ICT and Future Planning (MSIP)
ID : 2023R1A2C2003059

Informations de copyright

© 2024. The Author(s).

Références

Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486–541 (2018).
pubmed: 29362479 pmcid: 5864239 doi: 10.1038/s41418-017-0012-4
Darzynkiewicz, Z. et al. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27, 1–20 (1997).
pubmed: 9000580 doi: 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L
Zamzami, N., Hirsch, T., Dallaporta, B., Petit, P. X. & Kroemer, G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29, 185–193 (1997).
pubmed: 9239543 doi: 10.1023/A:1022694131572
Fairlie, W. D., Tran, S. & Lee, E. F. Crosstalk between apoptosis and autophagy signaling pathways. Int. Rev. Cell Mol. Biol. 352, 115–158 (2020).
pubmed: 32334814 doi: 10.1016/bs.ircmb.2020.01.003
Yang, Y. et al. Targeting regulated cell death with plant natural compounds for cancer therapy: a revisited review of apoptosis, autophagy-dependent cell death, and necroptosis. Phytother. Res. 37, 1488–1525 (2023).
pubmed: 36717200 doi: 10.1002/ptr.7738
Chen, D. Q., Guo, Y., Li, X., Zhang, G. Q. & Li, P. Small molecules as modulators of regulated cell death against ischemia/reperfusion injury. Med. Res. Rev. 42, 2067–2101 (2022).
pubmed: 35730121 doi: 10.1002/med.21917
Newton, K. et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature 574, 428–431 (2019).
pubmed: 31511692 doi: 10.1038/s41586-019-1548-x
Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal. Transduct. Target Ther. 7, 286 (2022).
pubmed: 35963853 pmcid: 9376115 doi: 10.1038/s41392-022-01110-y
Wu, J., Ye, J., Xie, Q., Liu, B. & Liu, M. Targeting regulated cell death with pharmacological small molecules: an update on autophagy-dependent cell death, ferroptosis, and necroptosis in cancer. J. Med Chem. 65, 2989–3001 (2022).
pubmed: 35130435 doi: 10.1021/acs.jmedchem.1c01572
Woo, Y., Lee, H. J., Jung, Y. M. & Jung, Y. J. Regulated necrotic cell death in alternative tumor therapeutic strategies. Cells 9 https://doi.org/10.3390/cells9122709 (2020).
Qin, R. et al. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. J. Hematol. Oncol. 15, 133 (2022).
pubmed: 36104717 pmcid: 9471064 doi: 10.1186/s13045-022-01350-z
Baron, O. & Fanto, M. Karyoptosis: a novel type of cell death caused by chronic autophagy inhibition. Autophagy 14, 722–723 (2018).
pubmed: 29388501 pmcid: 5959325 doi: 10.1080/15548627.2018.1434372
Napoletano, F., Baron, O., Vandenabeele, P., Mollereau, B. & Fanto, M. Intersections between regulated cell death and autophagy. Trends Cell Biol. 29, 323–338 (2019).
pubmed: 30665736 doi: 10.1016/j.tcb.2018.12.007
Versaevel, M., Riaz, M., Grevesse, T. & Gabriele, S. Cell conflinement: putting the squeeze on the nucleus. Soft Matter. 9, 6665 (2013).
doi: 10.1039/c3sm00147d
Liang, G. et al. Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress response protein Herp through an ER stress response element. Mol. Cell Biol. 26, 7999–8010 (2006).
pubmed: 16940180 pmcid: 1636730 doi: 10.1128/MCB.01046-06
Howley, B. V., Link, L. A., Grelet, S., El-Sabban, M. & Howe, P. H. A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer. Oncogene 37, 1308–1325 (2018).
pubmed: 29249802 doi: 10.1038/s41388-017-0023-0
Hetz, C. & Papa, F. R. The unfolded protein response and cell fate control. Mol. Cell 69, 169–181 (2018).
pubmed: 29107536 doi: 10.1016/j.molcel.2017.06.017
Reiling, J. H. et al. A CREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens. Nat. Cell Biol. 15, 1473–1485 (2013).
pubmed: 24185178 pmcid: 3965854 doi: 10.1038/ncb2865
Kang, H., Jang, S. W. & Ko, J. Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9. J. Biol. Chem. 286, 42072–42081 (2011).
pubmed: 22009750 pmcid: 3234971 doi: 10.1074/jbc.M111.272302
Eleveld-Trancikova, D. et al. DC-STAMP interacts with ER-resident transcription factor LUMAN which becomes activated during DC maturation. Mol. Immunol. 47, 1963–1973 (2010).
pubmed: 20546900 doi: 10.1016/j.molimm.2010.04.019
Martyn, A. C. et al. Luman/CREB3 recruitment factor regulates glucocorticoid receptor activity and is essential for prolactin-mediated maternal instinct. Mol. Cell Biol. 32, 5140–5150 (2012).
pubmed: 23071095 pmcid: 3510545 doi: 10.1128/MCB.01142-12
Sohn, M., Lee, J. E., Ahn, M., Park, Y. & Lim, S. Correlation of dynamic membrane fluctuations in red blood cells with diabetes mellitus and cardiovascular risks. Sci. Rep. 11, 7007 (2021).
pubmed: 33772071 pmcid: 7997877 doi: 10.1038/s41598-021-86528-0
Raggo, C. et al. Luman, the cellular counterpart of herpes simplex virus VP16, is processed by regulated intramembrane proteolysis. Mol. Cell Biol. 22, 5639–5649 (2002).
pubmed: 12138176 pmcid: 133973 doi: 10.1128/MCB.22.16.5639-5649.2002
Audas, T. E., Li, Y., Liang, G. & Lu, R. A novel protein, Luman/CREB3 recruitment factor, inhibits Luman activation of the unfolded protein response. Mol. Cell Biol. 28, 3952–3966 (2008).
pubmed: 18391022 pmcid: 2423117 doi: 10.1128/MCB.01439-07
Kim, J. & Ko, J. A novel PPARgamma2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation. Cell Death Differ. 21, 1642–1655 (2014).
pubmed: 24948012 pmcid: 4158692 doi: 10.1038/cdd.2014.80
Kamikawa, Y. et al. OASIS/CREB3L1 is a factor that responds to nuclear envelope stress. Cell Death Discov. 7, 152 (2021).
pubmed: 34226518 pmcid: 8257603 doi: 10.1038/s41420-021-00540-x
Taimen, P. et al. A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organization. Proc. Natl. Acad. Sci. USA 106, 20788–20793 (2009).
pubmed: 19926845 pmcid: 2779830 doi: 10.1073/pnas.0911895106
Cho, Y. Y. et al. The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction. Cancer Res. 65, 3596–3603 (2005).
pubmed: 15867353 doi: 10.1158/0008-5472.CAN-04-3935
Lu, C. et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol. Cell 23, 121–132 (2006).
pubmed: 16818236 pmcid: 2227311 doi: 10.1016/j.molcel.2006.05.023
Hetzer, M. W. The nuclear envelope. Cold Spring Harb. Perspect. Biol. 2, a000539–a000539 (2010).
pubmed: 20300205 pmcid: 2829960 doi: 10.1101/cshperspect.a000539
Seelbinder, B. et al. Nuclear deformation guides chromatin reorganization in cardiac development and disease. Nat. Biomed. Eng. 5, 1500–1516 (2021).
pubmed: 34857921 pmcid: 9300284 doi: 10.1038/s41551-021-00823-9
Schirmer, E. C., Florens, L., Guan, T., Yates, J. R. 3rd & Gerace, L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 301, 1380–1382 (2003).
pubmed: 12958361 doi: 10.1126/science.1088176
Cho, Y. Y. et al. RSK2 as a key regulator in human skin cancer. Carcinogenesis 33, 2529–2537 (2012).
pubmed: 22918890 pmcid: 3510733 doi: 10.1093/carcin/bgs271
Wang, M. L. et al. Andrographolide sodium bisulfate attenuates UV‑induced photo‑damage by activating the keap1/Nrf2 pathway and downregulating the NF‑kappaB pathway in HaCaT keratinocytes. Int J. Mol. Med. 45, 343–352 (2020).
pubmed: 31789424
Arul, N. & Cho, Y. Y. A rising cancer prevention target of RSK2 in human skin cancer. Front. Oncol. 3, 201 (2013).
pubmed: 23936765 pmcid: 3733026 doi: 10.3389/fonc.2013.00201
Maeda, T. et al. Role of p21(Waf-1) in regulating the G1 and G2/M checkpoints in ultraviolet-irradiated keratinocytes. J. Invest. Dermatol. 119, 513–521 (2002).
pubmed: 12190878 doi: 10.1046/j.1523-1747.2002.01828.x
Narayanan, D. L., Saladi, R. N. & Fox, J. L. Ultraviolet radiation and skin cancer. Int. J. Dermatol 49, 978–986 (2010).
pubmed: 20883261 doi: 10.1111/j.1365-4632.2010.04474.x
Takeuchi, H. & Runger, T. M. Longwave UV light induces the aging-associated progerin. J. Invest. Dermatol 133, 1857–1862 (2013).
pubmed: 23392295 doi: 10.1038/jid.2013.71
Wang, A. S. & Dreesen, O. Biomarkers of cellular senescence and skin aging. Front. Genet 9, 247 (2018).
pubmed: 30190724 pmcid: 6115505 doi: 10.3389/fgene.2018.00247
Song, J. H. et al. Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells. Mol. Carcinog. 58, 88–101 (2019).
pubmed: 30230030 doi: 10.1002/mc.22909
Caricchio, R., McPhie, L. & Cohen, P. L. Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J. Immunol. 171, 5778–5786 (2003).
pubmed: 14634086 doi: 10.4049/jimmunol.171.11.5778
Casterton, R. et al. Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress. Res. Sq. https://doi.org/10.21203/rs.3.rs-3287063/v1 (2023).
doi: 10.21203/rs.3.rs-3287063/v1
Lee, G. E., Byun, J., Lee, C. J. & Cho, Y. Y. Molecular mechanisms for the regulation of nuclear membrane integrity. Int J. Mol. Sci. 24, 15497 (2023).
pubmed: 37895175 pmcid: 10607757 doi: 10.3390/ijms242015497
Francois, F., Godinho, M. J. & Grimes, M. L. CREB is cleaved by caspases during neural cell apoptosis. FEBS Lett. 486, 281–284 (2000).
pubmed: 11119719 doi: 10.1016/S0014-5793(00)02316-4
Lee, C. J. et al. RSK2-induced stress tolerance enhances cell survival signals mediated by inhibition of GSK3beta activity. Biochem. Biophys. Res. Commun. 440, 112–118 (2013).
pubmed: 24055036 doi: 10.1016/j.bbrc.2013.09.042

Auteurs

Ga-Eun Lee (GE)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Geul Bang (G)

Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, Cheongju-si, Chungbuk, 28119, Republic of Korea.

Jiin Byun (J)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Cheol-Jung Lee (CJ)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
Research Center for Materials Analysis, Korea Basic Science Institute, Daejeon, 34133, Republic of Korea.

Weidong Chen (W)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Dohyun Jeung (D)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Hyun-Jung An (HJ)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Han Chang Kang (HC)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Joo Young Lee (JY)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Hye Suk Lee (HS)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Young-Soo Hong (YS)

Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju-si, Chungbuk, 28116, Republic of Korea.

Dae Joon Kim (DJ)

Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX, 78504, USA.

Megan Keniry (M)

Department of Biology, University of Texas Rio Grande Valley, Edinburg, TX, 78539, USA.

Jin Young Kim (JY)

Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, Cheongju-si, Chungbuk, 28119, Republic of Korea.

Jin-Sung Choi (JS)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Manolis Fanto (M)

Department of Basic and Clinical Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.

Sung-Jun Cho (SJ)

University of Minnesota, Department of Medicine, 420 Delaware St SE, MMC 284, Minneapolis, MN, 55455, USA.

Kwang-Dong Kim (KD)

Division of Applied Life Science (BK21 four), PMBBRC, Gyeongsang National University, Jinju, 52828, Korea.

Yong-Yeon Cho (YY)

College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea. yongyeon@catholic.ac.kr.
BK21-4th, and RCD Control∙Material Research Institute, College of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea. yongyeon@catholic.ac.kr.

Classifications MeSH